Full Text View
Tabular View
No Study Results Posted
Related Studies
Regional Citrate Anticoagulation in Plasma Exchange Treatment
This study is currently recruiting participants.
Verified December 2009 by University Medical Centre Ljubljana
Study NCT01370200   Information provided by University Medical Centre Ljubljana

First Received on June 2, 2011.   Last Updated on June 8, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Focal Segmental Glomerulosclerosis
Guillain-Barre Syndrome
Additional conditions recognized in this trial
Glomerulosclerosis, Focal Segmental
More general conditions related to this trial
Autoimmune Diseases
Autoimmune Diseases of the Nervous System
Demyelinating Diseases
Glomerulonephritis
Immune System Diseases
Kidney Diseases
Nephritis
Nervous System Diseases
Neuromuscular Diseases
Peripheral Nervous System Diseases
Polyneuropathies
Polyradiculoneuropathy
Urologic Diseases
Interventions listed in this trial
plasma exchange treatment
Additional drug interventions recognized in this trial
Citric Acid
More general drug interventions related to this trial
Anticoagulants
Chelating Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University Medical Centre Ljubljana


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services